Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jordan J Feld

Showing results (131-140 of 395) with videos related to

Pageof 40
Sort By:
Journal of Viral Hepatitis|October 16, 2020
Cost-effectiveness analysis of sofosbuvir and velpatasvir in chronic hepatitis C patients with decompensated cirrhosisJocelyn Chan, John J Kim, Brett K Barrett, et al.
Hepatology Communications|April 30, 2025
Hepatobiliary complications in patients with sickle cell disease: A 30-year review of 1009 patientsMaya Deeb, Kristel K Leung, Richard Ward, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|April 9, 2020
The emergency department as a setting-specific opportunity for population-based hepatitis C screening: An economic evaluationAndrew B Mendlowitz, David Naimark, William W L Wong, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 20, 2012
Hepatitis B virus screening before chemotherapy for lymphoma: a cost-effectiveness analysisUrszula Zurawska, Lisa K Hicks, Gloria Woo, et al.
Medical Decision Making : an International Journal of the Society for Medical Decision Making|February 22, 2025
Health Utilities in People with Hepatitis C Virus Infection: A Study Using Real-World Population-Level DataYasmin A Saeed, Nicholas Mitsakakis, Jordan J Feld, et al.
Virology Journal|September 19, 2020
Role of HVR1 sequence similarity in the cross-genotypic neutralization of HCVAlexander I Mosa, Mounir G AbouHaidar, Richard A Urbanowicz, et al.
Vaccine|September 9, 2020
A bivalent HCV peptide vaccine elicits pan-genotypic neutralizing antibodies in miceAlexander I Mosa, Richard A Urbanowicz, Mounir G AbouHaidar, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 14, 2023
Controlled Human Infection Model for Hepatitis C Virus Vaccine Development: Trial Design ConsiderationsJordan J Feld, Julie Bruneau, Gregory J Dore, et al.
Expert Review of Molecular Diagnostics|January 4, 2024
We have reached single-visit testing, diagnosis, and treatment for hepatitis C infection, now what?Jason Grebely, Susan Matthews, Louise M Causer, et al.
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|June 6, 2018
The management of chronic hepatitis C: 2018 guideline update from the Canadian Association for the Study of the LiverHemant Shah, Marc Bilodeau, Kelly W Burak, et al.
Pageof 40

Showing results (131-140 of 395) with videos related to

Sort By:
Pageof 40
Journal of Viral Hepatitis|October 16, 2020
Cost-effectiveness analysis of sofosbuvir and velpatasvir in chronic hepatitis C patients with decompensated cirrhosisJocelyn Chan, John J Kim, Brett K Barrett, et al.
Hepatology Communications|April 30, 2025
Hepatobiliary complications in patients with sickle cell disease: A 30-year review of 1009 patientsMaya Deeb, Kristel K Leung, Richard Ward, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|April 9, 2020
The emergency department as a setting-specific opportunity for population-based hepatitis C screening: An economic evaluationAndrew B Mendlowitz, David Naimark, William W L Wong, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 20, 2012
Hepatitis B virus screening before chemotherapy for lymphoma: a cost-effectiveness analysisUrszula Zurawska, Lisa K Hicks, Gloria Woo, et al.
Medical Decision Making : an International Journal of the Society for Medical Decision Making|February 22, 2025
Health Utilities in People with Hepatitis C Virus Infection: A Study Using Real-World Population-Level DataYasmin A Saeed, Nicholas Mitsakakis, Jordan J Feld, et al.
Virology Journal|September 19, 2020
Role of HVR1 sequence similarity in the cross-genotypic neutralization of HCVAlexander I Mosa, Mounir G AbouHaidar, Richard A Urbanowicz, et al.
Vaccine|September 9, 2020
A bivalent HCV peptide vaccine elicits pan-genotypic neutralizing antibodies in miceAlexander I Mosa, Richard A Urbanowicz, Mounir G AbouHaidar, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 14, 2023
Controlled Human Infection Model for Hepatitis C Virus Vaccine Development: Trial Design ConsiderationsJordan J Feld, Julie Bruneau, Gregory J Dore, et al.
Expert Review of Molecular Diagnostics|January 4, 2024
We have reached single-visit testing, diagnosis, and treatment for hepatitis C infection, now what?Jason Grebely, Susan Matthews, Louise M Causer, et al.
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|June 6, 2018
The management of chronic hepatitis C: 2018 guideline update from the Canadian Association for the Study of the LiverHemant Shah, Marc Bilodeau, Kelly W Burak, et al.
Pageof 40